{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:09:03Z","timestamp":1778623743186,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["MUHLEB11A1"],"award-info":[{"award-number":["MUHLEB11A1"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["SAGEL11A0"],"award-info":[{"award-number":["SAGEL11A0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006501","name":"Cystic Fibrosis Foundation Therapeutics","doi-asserted-by":"publisher","award":["ZIADY11A0"],"award-info":[{"award-number":["ZIADY11A0"]}],"id":[{"id":"10.13039\/100006501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["NIH\/NIDDKP30 DK089507"],"award-info":[{"award-number":["NIH\/NIDDKP30 DK089507"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["1 TR002535"],"award-info":[{"award-number":["1 TR002535"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jcf.2019.12.007","type":"journal-article","created":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T18:17:03Z","timestamp":1576865823000},"page":"632-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6172-4465","authenticated-orcid":false,"given":"Scott D.","family":"Sagel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandie D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assem","family":"Ziady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Clancy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Narvaez-Rivas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Pilewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Joseloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Zelnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.R.","family":"Setchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2696-2382","authenticated-orcid":false,"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6391-1598","authenticated-orcid":false,"given":"Marianne S.","family":"Muhlebach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2019.12.007_bib0001","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2016.10.009","article-title":"Biomarkers for cystic fibrosis drug development","volume":"15","author":"Muhlebach","year":"2016","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.12.007_bib0002","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jcf.2017.08.005","article-title":"Take it to the bank","volume":"16","author":"Clancy","year":"2017","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.12.007_bib0003","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The cystic fibrosis foundation patient registry. design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2019.12.007_bib0004","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2019.12.007_bib0005","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1513\/AnnalsATS.201410-493OC","article-title":"Effect of treatment of cystic fibrosis pulmonary exacerbations on systemic inflammation","volume":"12","author":"Sagel","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jcf.2019.12.007_bib0006","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJMoa021218","article-title":"Association of cystic fibrosis with abnormalities in fatty acid metabolism","volume":"350","author":"Freedman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2019.12.007_bib0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.plefa.2010.07.002","article-title":"Fatty acid metabolism in cystic fibrosis","volume":"83","author":"Strandvik","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.jcf.2019.12.007_bib0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ppul.22859","article-title":"Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis","volume":"49","author":"Joseloff","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.12.007_bib0009","series-title":"Analysis of health surveys","author":"Korn ELG","year":"1999"},{"key":"10.1016\/j.jcf.2019.12.007_bib0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cct.2009.01.003","article-title":"Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the epic clinical trial and observational study'","volume":"30","author":"Treggiari","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jcf.2019.12.007_bib0011","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0022-2275(20)38553-9","article-title":"Specific methylation of plasma nonesterified fatty acids in a one-step reaction","volume":"29","author":"Lepage","year":"1988","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jcf.2019.12.007_bib0012","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1021\/ac901536h","article-title":"Integrated, nontargeted ultrahigh performance liquid chromatography\/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems","volume":"81","author":"Evans","year":"2009","journal-title":"Anal Chem"},{"key":"10.1016\/j.jcf.2019.12.007_bib0013","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2217\/14622416.9.4.383","article-title":"Analysis of the adult human plasma metabolome","volume":"9","author":"Lawton","year":"2008","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jcf.2019.12.007_bib0014","doi-asserted-by":"crossref","first-page":"9440","DOI":"10.1073\/pnas.1530509100","article-title":"Statistical significance for genomewide studies","volume":"100","author":"Storey","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"10.1016\/j.jcf.2019.12.007_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/EDE.0b013e31806462d3","article-title":"Outcome-dependent sampling: an efficient sampling and inference procedure for studies with a continuous outcome","volume":"18","author":"Zhou","year":"2007","journal-title":"Epidemiology (Cambridge, Mass)"},{"key":"10.1016\/j.jcf.2019.12.007_bib0016","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/biom.12013","article-title":"Outcome vector dependent sampling with longitudinal continuous response data: stratified sampling based on summary statistics","volume":"69","author":"Schildcrout","year":"2013","journal-title":"Biometrics"},{"key":"10.1016\/j.jcf.2019.12.007_bib0017","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2019.12.007_bib0018","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcf.2010.12.004","article-title":"Change in igg and evolution of lung function in children with cystic fibrosis","volume":"10","author":"Proesmans","year":"2011","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2019.12.007_bib0019","first-page":"E173","article-title":"Plasma biomarkers and cystic fibrosis lung disease","volume":"35","author":"Cantin","year":"2012","journal-title":"Clinical and Investigative Medicine Medecine Clinique et Experimentale"},{"key":"10.1016\/j.jcf.2019.12.007_bib0020","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1164\/rccm.201407-1365LE","article-title":"Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis","volume":"191","author":"Reid","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.12.007_bib0021","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/thoraxjnl-2014-206710","article-title":"Discovery of novel plasma protein biomarkers to predict imminent cystic fibrosis pulmonary exacerbations using multiple reaction monitoring mass spectrometry","volume":"71","author":"Quon","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jcf.2019.12.007_bib0022","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1378\/chest.13-0693","article-title":"Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations","volume":"144","author":"Shoki","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2019.12.007_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcf.2019.05.020","article-title":"Blood biomarkers to predict short-term pulmonary exacerbation risk in children and adolescents with CF: a pilot study","volume":"19","author":"Singh","year":"2020","journal-title":"J Cystic Fibros Off J Eur Cystic Fibros Soc"},{"key":"10.1016\/j.jcf.2019.12.007_bib0024","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcf.2019.12.007_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/MPG.0b013e31817fb76b","article-title":"Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis","volume":"47","author":"Maqbool","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1542\/peds.2004-2832","article-title":"Temporal associations among energy intake, plasma linoleic acid, and growth improvement in response to treatment initiation after diagnosis of cystic fibrosis","volume":"117","author":"Shoff","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcf.2019.12.007_bib0027","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/MPG.0000000000001213","article-title":"Effect of oral lipid matrix supplement on fat absorption in cystic fibrosis: a randomized placebo-controlled trial","volume":"63","author":"Stallings","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0028","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajcn\/75.4.668","article-title":"Increased plasma fatty acid concentrations after respiratory exacerbations are associated with elevated oxidative stress in cystic fibrosis patients","volume":"75","author":"Wood","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0029","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2019.12.007_bib0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajhg.2014.12.022","article-title":"Gene expression in transformed lymphocytes reveals variation in endomembrane and HLA pathways modifying cystic fibrosis pulmonary phenotypes","volume":"96","author":"O'Neal","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcf.2019.12.007_bib0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1164\/rccm.201701-0134OC","article-title":"Airway mucosal host defense is key to genomic regulation of cystic fibrosis lung disease severity","volume":"197","author":"Polineni","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2019.12.007_bib0032","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ppul.23972","article-title":"Metabolomic responses to lumacaftor\/ivacaftor in cystic fibrosis","volume":"53","author":"Kopp","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.12.007_bib0033","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ppul.23225","article-title":"Metabolomics analysis identifies novel plasma biomarkers of cystic fibrosis pulmonary exacerbation","volume":"50","author":"Laguna","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2019.12.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2019.100010","article-title":"Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation","volume":"3","author":"Muhlebach","year":"2019","journal-title":"Metabolism Open"},{"key":"10.1016\/j.jcf.2019.12.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007191","article-title":"Para-cresol production by clostridium difficile affects microbial diversity and membrane integrity of gram-negative bacteria","volume":"14","author":"Passmore","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.jcf.2019.12.007_bib0036","first-page":"6","article-title":"Metabolic dysbiosis of the gut microbiota and its biomarkers","volume":"12","author":"Sitkin","year":"2016","journal-title":"Eksp Klin Gastroenterol"},{"key":"10.1016\/j.jcf.2019.12.007_bib0037","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.biocel.2016.10.021","article-title":"Tuning constitutive and pathological inflammation in the gut via the interaction of dietary nitrate and polyphenols with host microbiome","volume":"81","author":"Rocha","year":"2016","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jcf.2019.12.007_bib0038","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/ajcn\/87.6.1860","article-title":"Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality","volume":"87","author":"Watanabe","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0039","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-018-30764-4","article-title":"The human metabolic profile reflects macro- and micronutrient intake distinctly according to fasting time","volume":"8","author":"Sedlmeier","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcf.2019.12.007_bib0040","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MPG.0b013e3182618f33","article-title":"Relation between dietary fat intake type and serum fatty acid status in children with cystic fibrosis","volume":"55","author":"Maqbool","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0041","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MPG.0000000000001356","article-title":"Complex relation between diet and phospholipid fatty acids in children with cystic fibrosis","volume":"64","author":"Moukarzel","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jcf.2019.12.007_bib0042","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0009-8981(02)00100-6","article-title":"Stability of plasma and erythrocyte fatty acid composition during cold storage","volume":"321","author":"Hodson","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jcf.2019.12.007_bib0043","doi-asserted-by":"crossref","first-page":"E136","DOI":"10.25011\/cim.v41i3.30792","article-title":"Intermittent inhaled tobramycin and systemic cytokines response in CF patients with pseudomonas aeruginosa","volume":"41","author":"Toukan","year":"2018","journal-title":"Clin Invest Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319309865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199319309865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:23Z","timestamp":1778620463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199319309865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1569199319309865"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2019.12.007","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2019.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}